Category: Disclosures

[Disclosure] SK Square (402340) – Change in Revenue or Profit/Loss Structure Exceeding 30% (15% for Large Enterprises) / 2025-02-11

February 11, 2025July 31, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square has turned profitable in 2024 with a consolidated operating profit of KRW 3.91T, driven by increased profits from key associate SK Hynix and profit improvements in its ICT portfolio. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Final…

Semiconductors, Disclosures

[Disclosure] Hanwha Aerospace (012450) – Acquisition of Shares in Other Corporation / 2025-02-10

February 10, 2025August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace has disclosed its decision to acquire 22,375,216 shares of its affiliate, Hanwha Ocean, from other group affiliates for approximately KRW 1.30T via a block deal to enhance synergy and strengthen responsible management. 📊 [Key Disclosure Contents & Major Financial Figures] 1. Issuer (Target Company)…

Disclosures, Defense

[Disclosure] Hanwha Aerospace (012450) – Significant Changes in Revenue or Profit/Loss Structure / 2025-02-10

February 10, 2025August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace has disclosed a significant improvement in its financial performance for FY2024, reporting consolidated revenue of approximately KRW 11.25T (up 20.16% YoY) and operating profit of KRW 1.72T (up 149.55% YoY) due to sales growth and enhanced profitability. 📊 [Key Disclosure Contents & Major Financial…

Disclosures, Defense

[Disclosure] Hanwha Aerospace (012450) – Provisional Financial Results / 2025-02-10

February 10, 2025August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace has disclosed its provisional consolidated Q4 2024 financial results, reporting revenue of approximately KRW 4.83T and operating profit of KRW 892.5B (up 56.0% and 222.1% YoY, respectively), bringing full-year 2024 cumulative revenue to KRW 11.25T and operating profit to KRW 1.72T. 📊 [Key Disclosure…

Disclosures, Defense

[Disclosure] Hanwha Ocean (042660) – Execution of Single Sales or Supply Contract / 2025-02-10

February 10, 2025August 8, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Ocean has signed a contract worth KRW 732.2B with its affiliate Hanwha Shipping LLC to build two LNG carriers (LNGC). 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Potential Changes in Contract Period and Final Settlement Amount…

Disclosures, Shipbuilding

[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2025-02-10

February 10, 2025August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary The company will hold an IR session in Seoul for major overseas institutional investors by participating in the ‘Tech Tour’ sponsored by Nomura Securities to share its 2025 AI/HBM market outlook, next-generation HBM bonder roadmap, and new product lineup. 📊 [Key Disclosure Contents & Summary of…

Semiconductors, Disclosures

[Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Holding Announcement / 2025-02-10

February 10, 2025August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ISU PETASYS will hold in-person analyst meetings and participate in international tech conferences hosted by JP Morgan and Citi to review its FY2024 performance and present business outlooks. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Published IR…

Semiconductors, Disclosures

[Disclosure] Samsung Biologics (207940) – Measures Such as Prosecution Notice for Breach of Accounting Standards / 2025-02-10

February 10, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed that it confirmed an appeal filed by the Seoul Central District Prosecutors’ Office to the Supreme Court regarding the second-instance acquittal ruling on alleged accounting rule violations. The issues under appeal remain identical to the indictment filed on September 4, 2020. 📊…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Additional Listing (Exercise of Stock Options) / 2025-02-10

February 10, 2025August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion is issuing 41,475 additional common shares through the exercise of stock options, scheduled to be listed on February 13, 2025. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Total Share Count Adjustment Following Additional Listing This disclosure…

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Systems (272210) – Change in Revenue or Operating Profit/Loss by 30% or More / 2025-02-07

February 7, 2025August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems reported preliminary consolidated FY2024 revenue of KRW 2.80T, operating profit of KRW 219.3B, and net profit of KRW 445.2B. Revenue increased by 14.3% YoY, while operating profit surged by 78.9% YoY. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key Follow-up Checkpoint)…

Disclosures, Defense